Dexone | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Dexone
US Exclusivities

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Symbiotec Dexamethasone

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Contact Supplier

jdmfs-not-supported-m-2025-06-23

Dexone

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

95 API Suppliers, 27 USDMF, 12 CEP/COS, 6 JDMF, 4 EU WC, 7 KDMF, 26 NDC API, 1 VMF, 55 Listed Suppliers, $ API Reference Price

95 API Suppliers
27 USDMF
12 CEP/COS
6 JDMF
4 EU WC
7 KDMF
26 NDC API
1 VMF
55 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

236 Drugs in Development

236 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

365 FDF Dossiers, 130 FDA Orange Book, 113 Europe, 26 Canada, 10 Australia, 17 South Africa, 69 Listed Dossiers

365 FDF Dossiers
130 FDA Orange Book
113 Europe
26 Canada
10 Australia
17 South Africa
69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.1%, SUSPENSION/DROPS;OTIC - 0.3%;0.1%, OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM, SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%, OINTMENT;OPHTHALMIC - 0.1%;0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%, TABLET;ORAL - 0.5MG, TABLET;ORAL - 0.75MG, TABLET;ORAL - 1.5MG, TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, TABLET;ORAL - 4MG, TABLET;ORAL - 6MG, SOLUTION;ORAL - 0.5MG/5ML, ELIXIR;ORAL - 0.5MG/5ML

SUSPENSION/DROPS;OPHTHALMIC - 0.1%
SUSPENSION/DROPS;OTIC - 0.3%;0.1%
OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%
OINTMENT;OPHTHALMIC - 0.1%;0.3%
SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%
TABLET;ORAL - 0.5MG
TABLET;ORAL - 0.75MG
TABLET;ORAL - 1.5MG
TABLET;ORAL - 1MG
TABLET;ORAL - 2MG
TABLET;ORAL - 4MG
TABLET;ORAL - 6MG
SOLUTION;ORAL - 0.5MG/5ML
ELIXIR;ORAL - 0.5MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 7 SPI Pharma, 10 DKSH, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 6 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 15 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 10 Corel Pharma Chem, 1 Curia, 6 DFE Pharma, 3 Finar, 8 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 15 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 27 Thickeners and Stabilizers, 25 Solubilizers, 22 Direct Compression, 21 Controlled & Modified Release, 21 Parenteral, 21 Topical, 18 Film Formers & Plasticizers, 18 Co-Processed Excipients, 17 Disintegrants & Superdisintegrants, 16 Granulation, 16 Taste Masking, 12 Lubricants & Glidants, 11 Rheology Modifiers, 8 Chewable & Orodispersible Aids, 7 Emulsifying Agents, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

67 Fillers, Diluents & Binders
44 Coating Systems & Additives
27 Thickeners and Stabilizers
25 Solubilizers
22 Direct Compression
21 Controlled & Modified Release
21 Parenteral
21 Topical
18 Film Formers & Plasticizers
18 Co-Processed Excipients
17 Disintegrants & Superdisintegrants
16 Granulation
16 Taste Masking
12 Lubricants & Glidants
11 Rheology Modifiers
8 Chewable & Orodispersible Aids
7 Emulsifying Agents
5 Empty Capsules
5 API Stability Enhancers
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 270 News #PharmaBuzz

3 Data Compilation #PharmaFlow
270 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 110 Regulatory FDF Prices, 7 Annual Reports

7 US Medicaid Prescriptions
110 Regulatory FDF Prices
7 Annual Reports

MARKET PLACE

66 APIs, 59 FDF Dossiers

66 APIs
59 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents, 2 US Exclusivities, 3 Health Canada Patents

18 US Patents
2 US Exclusivities
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 EDQM, 6 USP, 2 JP, 8 Others

8 EDQM
6 USP
2 JP
8 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 665 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

2 All

01 1DEXCEL

02 1OCULAR THERAPEUTIX

filter Product Reset all filters

2 All

01 2DEXAMETHASONE

filter Exclusivity Expiration Date Reset all filters

2 All

01 12026-10-03

02 12028-04-07

filter Exclusivity Code Reset all filters

2 All

01 1NPP

02 1ODE-271

Product Main Page

DEXCEL

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DEXAMETHASONE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-271

Exclusivity Expiration Date

2026-10-03

Application Number

211379

Product Number

1

Exclusivity Details

01

DEXCEL

The Aesthetic Show

Not Confirmed

DEXCEL

Israel

The Aesthetic Show

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DEXAMETHASONE

Exclusivity Code : ODE-271

Exclusivity Expiration Date : 2026-10-03

Application Number : 211379

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OCULAR THERAPEUTIX

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DEXAMETHASONE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2028-04-07

Application Number

208742

Product Number

1

Exclusivity Details

02

OCULAR THERAPEUTIX

The Aesthetic Show

Not Confirmed

OCULAR THERAPEUTIX

U.S.A

The Aesthetic Show

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DEXAMETHASONE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2028-04-07

Application Number : 208742

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!